Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The Hague, Nijmegen, Utrecht and Veldhoven. Corius is the largest network of dermatology and phlebology practices in Germany and Switzerland.
By acquiring Mauritskliniek, Corius geographically expands its European healthcare offerings to the Netherlands. Both the services and vision of Mauritskliniek are perfectly consistent with those of Corius.
Mauritskliniek intends to join Corius in the third quarter of 2022, after potential approval of the Nederlandse Zorgautoriteit (NZa).
About Corius
Corius is a network of dermatology and phlebology practices. Doctors and partners of Corius deliver the highest level of quality and apply the most modern technology. An absolute passion for the job and patients is pivotal in the way of working. Corius offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. Employees follow additional education and trainings throughout. Corius has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year. www.corius.de
About Mauritskliniek
Mauritskliniek is a specialized clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working. Their values are personal, clear and well organized. The clinics offer both insured and uninsured care. Customer satisfaction is rated with 8.6/10 points, according zorgkaartnederland.nl. www.maurtiskliniek.nl
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
Holland Capital invests in ComplianceWise
Amsterdam, 6 September 2022 - Investment company Holland Capital provides growth finance to ComplianceWise, a SaaS company that offers solutions to financial institutions and service providers such as accountants and tax advisors. These partners deal with growing...
OnePLM is joining the consortium of Magnus Digital, Dimensys, cards PLM Solutions and Appronto
September 1st, 2022 – The Digital Transformation consortium of Magnus Digital, Dimensys, cards PLM Solutions and Appronto, along with the main shareholder Holland Capital, is investing in OnePLM. This collaboration complements the product and service offering and...
Eshgro attracts new investor for further growth
Boxmeer/Blaricum, August 31, 2022 - Strikwerda Investments (SI) becomes the new majority shareholder of IT service provider Eshgro, headquartered in Boxmeer (NL) and merges Eshgro with its portfolio company Total Specific Hosting (TSH). SI takes a majority share in...
Holland Capital invests in nanotech company Kriya Materials
Amsterdam August 5, 2022 – Holland Capital is investing in Kriya Materials (Kriya), a leading developer of advanced nanotechnology-based custom coating solutions. The funding will be used to accelerate international expansion. Advanced coating solutions Kriya...
Holland Capital invests in Health IT company Open HealthHub
Amsterdam, 26 July 2022 – Holland Capital is investing in Open HealthHub, a digital platform that allows healthcare providers and patients to exchange medical data safely and securely. It will also reduce the administrative burden on healthcare providers. The...
Holland Capital realizes successful exit of Humeca to i4hi
Holland Capital realizes successful exit of Humeca to i4hi Borne / Amsterdam, 5 July 2022 – Investment company Holland Capital realizes a successful exit of Humeca to fellow investor i4hi. Humeca is a leading supplier of innovative products in the field of advanced...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01




